Protease Activation and Glucocorticoid-Induced Apoptosis in Chronic Lymphocytic Leukemia

References

• Cohen G. M. Caspases: the executioners of apoptosis. Bio‐chem. J. 1997; 326: 1–16
   PubMed Web of Science ®Google Scholar
• Hengartner M. O., Horvitz H. R. Programmed cell death in Caenorhabditis elegans. Curr. Op. Genet. Dev. 1994; 4: 581–586
   PubMed Web of Science ®Google Scholar
• Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G. Specific proteolytic cleavage of puly(ADP‐ribose) polymerase: An early marker of cheniotherapy‐induced apoptosis. Cancer Res. 1993; 53: 3976–3985
   PubMed Web of Science ®Google Scholar
• Nicholson D. W., Ali A., Thornbemy N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Lahelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T. T., Yu V. L., Miller D. K. Identification and inhibition of the ICE/ced‐3 protease necessary for mainmalian apoptosis. Nature. 1995; 376: 37–43
   PubMed Web of Science ®Google Scholar
• Kuida K., Zheng T. S., Na S., Kuan C., Yang D., Kara‐suyama H., Rakic P., Flavell R. A. Decreased apoptosis in the brain and premature lethality in CPP32deficient mice. Nature. 1996; 384: 368–372
   PubMed Web of Science ®Google Scholar
• Chandra J., Gilbreath J., Freireich E. J., Kliche K. O., Andreeff M., Keating M., McConkey D. J. Protease activation is required for glucocorticoid‐induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood. 1997; 90: 3673–3681
   PubMed Web of Science ®Google Scholar
• Bellosillo B. D. M., Colomer D., Gil J. Involvement of CED‐3/ICE proteases in the apoptosis of B‐chronic lymphocytic leukemia cells. Blood. 1997; 89: 3378–3384
   PubMed Web of Science ®Google Scholar
• Krajewski S. G. R., Zapata J. M., Krajewska M., Kitada S., Chhanabhai M., Horsman D., Berean K., Piro L. D., Fugier‐Vivier I., Liu Y. J., Wang H. G., Reed J. C. Immunolocal‐ization of the ICE/Ced‐3‐family protease, CPP‐32 (Caspase‐3), in non‐Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes. Blood. 1997; 89: 3817–3825
   PubMed Web of Science ®Google Scholar
• Kroemer G., Zamzami N., Susin S. A. Mitochondrial control of apoptosis. Immunol. Today. 1997; 18: 44–52
   PubMedGoogle Scholar
• Liu X., Kim C. N., Yang J., Jemmerson R., Wang X. Induction of the apoptotic program in cell‐free extracts: requirement for dATP and cytochrome c. Cell. 1996; 86: 147–157
   PubMed Web of Science ®Google Scholar
• Kluck R. M., Bossy‐Wetzel E., Green D. R., Newm‐eyer D. D. The release of cytochrome c from mitochondria: a primary site for bcl‐2 regulation of apoptosis. Science. 1997; 275: 1132–1136
   PubMed Web of Science ®Google Scholar
• Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP‐dependent formation of Apaf‐ 1/caspase‐9 complex initiates an apoptotic protease cascade. Cell. 1997; 91: 479–489
   PubMed Web of Science ®Google Scholar
• Zou H., Henzel W. J., Liu X., Lutschg A., Wang X. Apaf‐1, a human protein homologous to C. elegans ced‐4, participates in cytochrome c‐dependent activation of caspase‐3. Cell. 1997; 90: 405–413
   PubMed Web of Science ®Google Scholar
• Hu Y., Benedict M. A., Wu D., Inohara N., Nunez G. BCL‐XL interacts with Apaf‐ 1 and inhibits Apaf‐1‐dependent caspase‐9 activation. Proc. Natl. Acad. Sci. USA. 1998; 95: 4386–4391
   PubMed Web of Science ®Google Scholar
• Pan G., Humke E. W., Dixit V. M. Activation of caspases triggered by cytochrome c in vitro. FEBS Lett. 1998; 426: 151–154
   PubMed Web of Science ®Google Scholar
• Chandra J., Niemer I., Gilbreath J., Kliche K. O., Andreeff M., Freireich E. J., Keating M., McConkey D. J. Pro‐teasome inhibitors induce apoptosis in gluctrcorticoid‐resis‐tant chronic lymphocytic leukemic lymphocytes. Blood 1998, submitted
   PubMed Web of Science ®Google Scholar
• Zwaal R. F. A., Schroit A. J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997; 89: 1121–1132
   PubMed Web of Science ®Google Scholar
• Fadok V. A., Voelker D. R., Campbell P. A., Cohen J. J., Bratton D. L., Henson P. M. Exposure uf phosphati‐dylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 1992; 148: 2207–2216
   PubMed Web of Science ®Google Scholar
• Savill J., Fadok V., Henson P., Haslett C. Phagocytic recognition of cells undergoing apoptosis. Immunol, Today. 1993; 14: 131–136
   PubMedGoogle Scholar
• Albert M. L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class restricted CTLs. Nature. 1998; 392: 86–89
   PubMed Web of Science ®Google Scholar
• Vanags D. M., Porn‐Ares M. I., Coppola S., Burgess D. H., Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 1996; 271: 31075–31085
   PubMed Web of Science ®Google Scholar
• Martin S. J., O'Brien G. A., Nishioka W. K., McGahon A. J., Mahhoubi A., Saido T. C., Green D. R. Proteolysis of fodrin (non‐erythroid spectrin) during apoptosis. J, Biol. Chem. 1995; 270: 6425–6428
   PubMed Web of Science ®Google Scholar
• Liu X., Zou H., Slaughter C., Wang X. DFF, a het‐erodimeric protein that functions downstream of caspase‐3 to trigger DNA fragmentation during apoptosis. Cell. 1997; 89: 175–184
   PubMed Web of Science ®Google Scholar
• Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase‐activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998; 391: 43–50
   PubMed Web of Science ®Google Scholar
• Collins R. J., Verschuer L. A., Harmon B. V., Prentice R. L., Pope J. H., Kerr J. F. R. Spontaneous programmed cell death (apoptosis) of B‐chronic lymphocytic leukemia cells following their culture in vitro. Br, J. Hematol. 1989; 71: 343–350
   PubMed Web of Science ®Google Scholar
• McConkey D. J., Aguilar‐Santelises M., Hartzell P., Eriksson I., Mellstedt H., Orrenius S., Jondal M. Induction of DNA fragmentation in chronic Blymphocytic leukemia cells. J, Immunol. 1991; 146: 1072–1076
   PubMed Web of Science ®Google Scholar
• Robertson L. E., Chubb S., Meyn R. E., Story M., Ford R., Hittelman W. N., Plunkett W. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2‐chloro‐2′‐deoxyadenosine and 9‐beta‐D‐arabino‐syl‐2′‐tluroadenine. Blood. 1993; 81: 143150
   Google Scholar
• McConkey D. J., Chandra J., Wright S., Plunkett W., McDonnell T. J., Reed J. C., Keating M. J. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL‐2 and BAX. J, Immunol. 1996; 156: 2624–2630
   PubMed Web of Science ®Google Scholar
• McConkey D. J. Calcium‐dependent, interleukin 1b‐convert‐ing enzyme (ICE) inhibitor‐insensitive degradation of lamin B 1 and DNA fragmentation in isolated thymocyte nuclei. J. Biol. Chem. 1996; 271: 22398–22406
   PubMed Web of Science ®Google Scholar
• Kaufmann S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etopo‐side, camptothecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res. 1989; 49: 5870–5878
   PubMed Web of Science ®Google Scholar
• Clawson G. A., Norbeck L. L., Hatem C. L., Rhodes C., Amiri P., McKerrow J. H., Patierno S. R., Fiskum G. Ca2+‐regulated serine protease associated with the nuclear scaffold. Cell Growth. & Differentiation. 1992; 3: 827–838
   PubMedGoogle Scholar
• Goldberg A. L. Functions of the proteasome: The lysis at the end of the tunnel. Science. 1995; 268: 522–523
   PubMed Web of Science ®Google Scholar
• Schwartz L. M., Smith S. W., Jones M. E. E., Osbome B. A. Do all programmed cell deaths occur via apoptosis?. Proc. Natl. Acad. Sci. USA. 1993; 90: 980–984
   PubMed Web of Science ®Google Scholar
• Grimm L. M., Goldberg A. L., Poirier G. G., Schwartz L. M., Osbome B. A. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 1996; 15: 3835–3844
   PubMed Web of Science ®Google Scholar
• Sadoul R., Fernandez P. A., Quiquerez A. L., Martinou I., Maki M., Schroter M., Becherer J. D., Irmler M., Tschopp J., Martinou J. C. Involvement of the proteasome in the programmed cell death of NGF‐deprived sympathetic neurons. EMBO J. 1996; 15: 3845–3852
   PubMed Web of Science ®Google Scholar
• Drexler H. C. A. Programmed cell death and the proteasome. Apoptosis. 1998; 3: 1–7
   PubMed Web of Science ®Google Scholar
• Delic J., Masdehors P., Omura S., Cosset J. M., Dumont J., Binet J. L., Magdelenat H. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo‐ and radioresistant human chronic lymphocytic leukaemic lymphocytes to TNF alpha‐initiated apoptosis. Br, J. Cancer. 1998; 77: 1103–1107
   PubMed Web of Science ®Google Scholar
• Forbes I. I., Zalewski P. D., Giannakis C., Cowled P. A. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp. Cell Res. 1992; 198: 367–372
   PubMed Web of Science ®Google Scholar
• Panayiotidis P., Ganeshaguru K., Jabbar S. A. G., Hoff‐brand A. V. Interleukin‐4 inhibits apoptotic cell death and loss of the BCL‐2 protein in B‐chronic lymphocytic leukemia cells in vitro. Br, J. Haematol. 1993; 85: 439–445
   PubMed Web of Science ®Google Scholar
• Dancescu M., Ruhio‐Trujillo M., Biron G., Bran D., Delespesse G., Sarfati M. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates BCL‐2 expression. J, Exp. Med. 1992; 176: 1319–1326
   PubMed Web of Science ®Google Scholar
• Buschle M., Campana D., Carding S. R., Richard C., Hoff‐brand A. V., Brenner M. K. Interferon g inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J, Exp. Med. 1993; 177: 213–218
   PubMed Web of Science ®Google Scholar
• Panayiotidis P., Jones D., Ganeshaguru K., Foroni L., Hofforand A. V. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br, J. Haematol. 1996; 92: 97–103
   PubMed Web of Science ®Google Scholar
• Reed J. C. Double identity for proteins of the BCL‐2 family. Nature. 1997; 387: 773776
   Web of Science ®Google Scholar
• McDonnell T. J., Deane N., Platt F. M., Nunez G., Jaeger U., McKearn J. P., Korsmeyer S. J. Bcl‐2‐immunoglob‐ulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989; 57: 79–88
   PubMed Web of Science ®Google Scholar
• McDonnell T. J., Korsmeyer S. J. Progression from lym‐phoid hyperplasia to high‐grade malignant lymphoma in mice transgenic for the t(14;18). Nature. 1990; 349: 254256
   Google Scholar
• Hockenbery D. M., Nunez G., Milliman C., Schreiber R. D., Korsmeyer S. J. BCL‐2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990; 348: 334–336
   PubMed Web of Science ®Google Scholar
• Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., Wang X. Prevention of apoptosis by bcl‐2: release of cytochrome c from mitochondria blocked. Science. 1997; 275: 1129–1132
   PubMed Web of Science ®Google Scholar
• Chinnaiyan A. M., O'Rourke K., Lane B. R., Dixit V. M. Interaction of ced‐4 with ced‐3 and ced‐9: a molecular framework for cell death. Science. 1997; 275: 11221126
   Web of Science ®Google Scholar
• Kane D. J., Sarafian T. A., Anton R., Hahn H., Gralla E. B., Valentine J. S., Ord T., Bredesen D. E. BCL‐2 inhibition of neural death: Decreased generation of reactive oxygen species. Science. 1993; 262: 1274–1277
   PubMed Web of Science ®Google Scholar
• Mirkovic N., Voehringer D. W., Story M. D., McConkey D. J., McDonnell T. J., Meyn R. E. Resistance to radiation‐induced apoptosis in BCL‐2‐expressing cells is reversed by depleting cellular thiols. Oncogene. 1997, in press
   PubMed Web of Science ®Google Scholar
• Voehringer D., McConkey D. J., McDonnell T., Brisbay S., Meyn R. E. BCL‐2 causes redistribution of glutathione to the nucleus. Proc, Natl. Acad. Sci. 1998; 95: 2956–2960
   PubMed Web of Science ®Google Scholar
• Mariano M. T., Moretti L., Donelli A., Grantini M., Montagnani G., Prisco A. U. D., Torelli G., Torelli U., Narni F. BCL‐2 gene expression in hematopoietic cell differentiation. Blood. 1992; 80: 768–775
   PubMed Web of Science ®Google Scholar
• Hanada M., Delia D., Aiello A., Stadtmauer E., Reed J. C. bcl‐2 gene hypomethylation and high‐level expression in B‐cell chronic lymphocytic leukemia. Blood. 1993; 82: 1820–1828
   PubMed Web of Science ®Google Scholar
• Consoli U., EI‐Tounsi I., Sandoval A., Suell V., Kleine H. D., Brown W., Robinson J. R., DiRaimondo F., Plunkett W., Andreeff M. Differential induction of apoptosis by fludarabine monophoshate in leukemic B and normal T cells in chronic lymphocytic leukemia. Blood. 1998; 91: 1742–1748
   PubMed Web of Science ®Google Scholar
• Kitada S., Andersen J., Akar S., Zapata J. M., Takayama S., Krajewski S., Wang H. G., Zhang X., Bullrich F., Croce C. M., Rai K., Hines J., Reed J. C. Expression of apoptosis‐regulatory proteins in chronic lymphocytic leukemia: correlations with in vitro and invivo chemore‐sponses. Blood. 1998; 91: 3379–3389
   PubMed Web of Science ®Google Scholar
• Baeuerle P. A., Baltimore D. NF‐kB: Ten Years After. Cell. 1996; 87: 13–20
   PubMed Web of Science ®Google Scholar
• Wu M., Lee H., Bellas R. E., Schauer S. L., Arsura M., Katz D., FitzGerald M. J., Rothstein T. L., Sherr D. H., Sonenshein G. E. Inhibition of NFkB/Rel induces apoptosis of murine B cells. EMBO J. 1995; 15: 4682–4690
   Web of Science ®Google Scholar
• Auphan N., DiDonato J. A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NFkB activity through induction of lkBa synthesis. Science. 1995; 270: 286–290
   PubMed Web of Science ®Google Scholar
• Devereaux Q. L., Takahashi R., Salvesen G. S., Reed J. C. X‐linked IAP is a direct inhibitor of cell‐death proteases. Nature. 1997; 388: 300–304
   PubMed Web of Science ®Google Scholar
• Vrhovac R., Delmer A., Tang R., Marie J. P., Zittoun R. F. AjchenbaumCymbalista Prognostic significance of the cell cycle inhibitor p27kipl in chronic lymphocytic leukemia. Blood. 1998; 91: 4694–4700
   PubMed Web of Science ®Google Scholar